Abiopharma

🔍 Walker Maria C (Executive)

Company: MapLight Therapeutics, Inc. (MPLT)

Report Date: 2026-06-23

Detailed Transactions and Holdings:

• Acquired 3,932 shares of Voting Common Stock (Direct)
  Date: 2026-06-23 | Code: A | equity_swap_involved: 0 | shares_owned_after: 62,703.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 14,902 shares of Stock Option (right to buy) at $28.64 per share (Derivative)
  Date: 2026-06-23 | Code: A | Expires: 2036-06-22 | equity_swap_involved: 0 | shares_owned_after: 14,902.00 | transaction_form_type: 4 | Footnotes: F3

Footnotes:

• F1: Represents restricted stock units ("RSUs") granted pursuant to the Issuer's 2025 Equity Incentive Plan (the "Plan"). The RSUs will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.
• F2: Each RSU represents a contingent right to receive one share of voting common stock of the Issuer.
• F3: Represents a stock option granted pursuant to the Plan. The shares subject to this stock option will vest on the earlier of (i) June 23, 2027, or (ii) the date of the Issuer's next annual stockholder meeting, subject to the Continuous Service (as defined in the Plan) of the Reporting Person as of the applicable vesting date. This grant was made pursuant to the Issuer's non-employee director compensation policy.